1.Oxidative stress is associated with the number of components of metabolic syndrome: LIPGENE study.
Elena Maria YUBERO-SERRANO ; Javier DELGADO-LISTA ; Patricia PENA-ORIHUELA ; Pablo PEREZ-MARTINEZ ; Francisco FUENTES ; Carmen MARIN ; Isaac TUNEZ ; Francisco JOSE TINAHONES ; Francisco PEREZ-JIMENEZ ; Helen M ROCHE ; Jose LOPEZ-MIRANDA
Experimental & Molecular Medicine 2013;45(6):e28-
Previous evidence supports the important role that oxidative stress (OxS) plays in metabolic syndrome (MetS)-related manifestations. We determined the relationship between the number of MetS components and the degree of OxS in MetS patients. In this comparative cross-sectional study from the LIPGENE cohort, a total of 91 MetS patients (43 men and 48 women; aged between 45 and 68 years) were divided into four groups based on the number of MetS components: subjects with 2, 3, 4 and 5 MetS components (n=20, 31, 28 and 12, respectively). We measured ischemic reactive hyperemia (IRH), plasma levels of soluble vascular cell adhesion molecule-1 (sVCAM-1), total nitrite, lipid peroxidation products (LPO), hydrogen peroxide (H2O2), superoxide dismutase (SOD) and glutathione peroxidase (GPx) plasma activities. sVCAM-1, H2O2 and LPO levels were lower in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. IRH and total nitrite levels were higher in subjects with 2 or 3 MetS components than subjects with 4 or 5 MetS components. SOD and GPx activities were lower in subjects with 2 MetS components than subjects with 4 or 5 MetS components. Waist circumference, weight, age, homeostatic model assessment-beta, triglycerides (TGs), high-density lipoprotein and sVCAM-1 levels were significantly correlated with SOD activity. MetS subjects with more MetS components may have a higher OxS level. Furthermore, association between SOD activity and MetS components may indicate that this variable could be the most relevant OxS biomarker in patients suffering from MetS and could be used as a predictive tool to determine the degree of the underlying OxS in MetS.
Aged
;
Anthropometry
;
Antioxidants/metabolism
;
Biological Markers/metabolism
;
Blood Pressure
;
Endothelium, Vascular/pathology/physiopathology
;
Female
;
Glutathione Peroxidase/blood
;
Humans
;
Hydrogen Peroxide/metabolism
;
Hyperemia/blood/physiopathology
;
Male
;
Metabolic Syndrome X/blood/enzymology/*pathology/physiopathology
;
Middle Aged
;
Nitrites/blood
;
*Oxidative Stress
;
Regression Analysis
;
Superoxide Dismutase/blood
;
Vascular Cell Adhesion Molecule-1/metabolism
2.Secondary male hypogonadism: A prevalent but overlooked comorbidity of obesity.
MarIa MOLINA-VEGA ; Araceli MUÑOZ-GARACH ; Miguel DAMAS-FUENTES ; José Carlos FERNÁNDEZ-GARCÍA ; Francisco J TINAHONES
Asian Journal of Andrology 2018;20(6):531-538
Male hypogonadism associated with obesity is a very prevalent condition and is increasing in parallel with the epidemic prevalence of obesity. Low testosterone levels promote higher fat mass with reduced lean mass. Male hypogonadism is related to an increase in associated cardiometabolic complications, such as hypertension, type 2 diabetes mellitus, the metabolic syndrome, and cardiovascular disease. Its influence as a comorbidity of obesity is becoming more evident and should be evaluated and treated in at-risk patients. Mechanisms involved in this relationship include body composition changes, the presence of adipokines, insulin resistance, and other factors, some of which are still unknown. Weight loss and treatment to replace testosterone levels improve the metabolic profile and quality of life in patients with obesity and hypogonadism; these beneficial effects depend on treatment modality and duration of therapy. The use of testosterone replacement therapy may be indicated, as it has not been shown to increase cardiovascular risk, and retrospective studies suggest a reduction in events in men with metabolic syndrome and type 2 diabetes.
Adult
;
Humans
;
Hypogonadism/epidemiology*
;
Male
;
Obesity/epidemiology*
;
Prevalence